Nitinol Medical Devices

Nitinol Medical Devices Market Outlook

The global Nitinol medical devices market is projected to reach approximately USD 8.27 billion by 2035, growing at a compound annual growth rate (CAGR) of about 10.1% during the forecast period of 2025-2035. This growth can be attributed to the increasing demand for minimally invasive surgical procedures, which utilize Nitinol-based devices due to their unique properties, including flexibility, biocompatibility, and shape memory characteristics. Furthermore, the rising prevalence of chronic diseases such as cardiovascular disorders and orthopedic conditions is driving the need for advanced medical devices that can enhance patient outcomes and recovery times. Additionally, technological advancements and innovations in Nitinol manufacturing processes are providing new opportunities for market expansion by improving device performance and reducing production costs. The growing geriatric population globally, coupled with a surge in healthcare spending, is expected to further fuel the growth of this market in the coming years.

Growth Factor of the Market

One of the primary growth factors for the Nitinol medical devices market is the increasing prevalence of cardiovascular diseases, which necessitate the use of advanced medical devices such as stents and other interventions that leverage Nitinol’s unique properties. Moreover, the shift towards minimally invasive surgeries is creating a significant demand for Nitinol components, as they provide flexibility and can easily navigate through complex anatomical structures. Regulatory approvals and clinical validations for new Nitinol-based devices are further contributing to market growth, as healthcare providers seek to utilize technologies that have demonstrated effectiveness and safety. The expanding applications of Nitinol in various medical fields, including orthopedics and neurology, are also enhancing market potential, as they address a variety of clinical needs. In addition, the rise in investment from public and private healthcare sectors in developing regions is fostering innovation in Nitinol technologies, thereby driving the market forward.

Key Highlights of the Market

• Significant CAGR of 10.1% projected from 2025 to 2035, indicating robust market growth.
• Increasing adoption of minimally invasive procedures, boosting demand for Nitinol-based devices.
• Expansion of applications across various medical fields, including cardiovascular, orthopedic, and neurological sectors.
• Technological advancements improving device performance and manufacturing efficiency.
• Growing investment in healthcare infrastructure in developing regions facilitating market expansion.

By Product Type

Stents :

Stents are one of the most widely used Nitinol medical devices, primarily employed in the treatment of cardiovascular diseases. Their design allows for expansion within arteries, ensuring that blood vessels remain open after procedures like angioplasty. The unique shape memory effect of Nitinol stents provides them with superior flexibility and adaptability to the anatomical structure of the arteries, reducing the risk of complications. Furthermore, advancements in coated stents are enabling better drug delivery systems, improving patient outcomes significantly. As the prevalence of coronary artery diseases continues to rise, the demand for Nitinol stents is expected to increase, further solidifying their position in the market.

Guidewires :

Nitinol guidewires are essential tools used in various interventional procedures, allowing for the navigation of catheters through the vascular system. The inherent flexibility and torqueability of Nitinol provide guidewires with the ability to maneuver through complex anatomy without causing trauma to the surrounding tissues. Moreover, advancements in the design and coating of guidewires have enhanced their performance and reliability, fostering greater trust among healthcare professionals. As the volume of interventional procedures continues to rise, the demand for high-quality Nitinol guidewires is expected to increase significantly, driven by the need for improved procedural efficiency and patient safety.

Filters :

Nitinol filters are primarily utilized for preventing embolisms by capturing blood clots in the venous system. The properties of Nitinol allow these filters to be deployed in a minimally invasive manner while maintaining structural integrity and effectiveness. The growing awareness of the risks associated with deep vein thrombosis and pulmonary embolism has led to increased use of these filters in clinical settings. Moreover, continuous innovations in filter designs, such as retrievable options that can be removed after the risk period, are expanding their application and usability in patient management. The expected rise in surgical procedures that require embolism management will further propel the demand for Nitinol filters.

Catheters :

Nitinol catheters have emerged as critical devices in various medical applications, including cardiovascular, urological, and endovascular procedures. Their flexibility and resistance to kinking enable better navigation through tight bends in vascular anatomy, while their shape memory properties allow for effective delivery of therapies. The increasing incidence of diseases requiring catheterization, such as heart disease and chronic kidney conditions, is driving the market for Nitinol catheters. Moreover, advancements in design and technology are enhancing their functionality, safety, and ease of use, making them an essential component of modern medical practice.

Retrieval Devices :

Nitinol retrieval devices are utilized for the extraction of foreign objects from the body, particularly in interventional radiology and endovascular procedures. The properties of Nitinol allow for the creation of devices that can expand and contract, enabling efficient retrieval of various materials without damaging surrounding tissues. As the number of procedures requiring foreign body retrieval increases, so does the demand for advanced Nitinol devices. Continuous research and development in this field are enhancing the effectiveness of these retrieval devices, leading to improved patient outcomes and increased adoption within clinical practices.

By Application

Endovascular :

The endovascular application of Nitinol medical devices has gained significant traction due to the increasing number of vascular interventions performed globally. These devices, including stents and guidewires, are critical in procedures aimed at treating a variety of vascular diseases, including peripheral artery disease and abdominal aortic aneurysms. The flexibility and shape memory characteristics of Nitinol enable these devices to conform to the anatomy of the blood vessels, improving procedural efficiency and reducing complications. As the prevalence of vascular diseases continues to rise, the demand for Nitinol devices in endovascular applications is expected to grow, driven by both procedural demands and technological advancements.

Orthopedic :

Nitinol medical devices are increasingly utilized in orthopedic applications, particularly in bone fixation and repair solutions. The unique properties of Nitinol, such as its superelasticity and biocompatibility, make it an ideal material for devices like bone screws and plates. The growing prevalence of orthopedic injuries and conditions, along with a rising elderly population, is driving the demand for innovative solutions that can improve recovery times and outcomes. As new products leveraging Nitinol technology are introduced into the market, the orthopedic segment is expected to experience significant growth, contributing to the overall expansion of the Nitinol devices market.

Dental :

The utilization of Nitinol in dental applications has gained popularity, particularly in orthodontics and endodontics. Nitinol wires and files are known for their flexibility, allowing for better adaptation to the dental anatomy while providing effective treatment solutions. The demand for aesthetic dental solutions, coupled with advancements in dental technologies, is driving the growth of Nitinol-based devices in this field. The increasing awareness of oral health and the rising number of dental procedures further support the expansion of this segment, indicating a positive outlook for Nitinol devices in dental applications.

Neurology :

Nitinol devices in the neurology application segment primarily focus on interventions related to neurovascular issues, including the treatment of aneurysms and vascular malformations. The combination of biocompatibility and mechanical properties of Nitinol makes it suitable for the development of specialized devices such as vascular stents and embolization coils. The rising incidence of neurological disorders requiring interventional procedures is driving the demand for Nitinol devices in this field. As technological advancements continue to evolve the designs and functionalities of these devices, the neurology segment is expected to see increased adoption and growth.

Urology :

The application of Nitinol devices in urology has expanded significantly, primarily in the treatment of urinary tract obstructions and calculi. Nitinol ureteral stents are highly effective in maintaining patency in the urinary system, while their unique properties ensure compatibility with the body's tissues. The growing incidence of urological conditions, alongside an increasing preference for minimally invasive procedures, is contributing to the expansion of this segment. As more healthcare providers adopt Nitinol technology for urological applications, the demand for these specialized devices is expected to rise, positively impacting the market.

By Distribution Channel

Hospitals :

Hospitals remain the primary distribution channel for Nitinol medical devices, accounting for a significant share of the market. The rising number of surgical procedures performed in hospitals, along with the increasing adoption of advanced medical technologies, drives demand for Nitinol-based solutions. Hospitals often have established procurement processes and relationships with manufacturers, allowing for a steady supply of high-quality devices. Furthermore, the trend towards providing comprehensive care within hospital settings enhances the use of Nitinol devices across various departments, from cardiology to orthopedics, ensuring a continuous growth trajectory for this channel.

Specialty Clinics :

Specialty clinics have emerged as a critical distribution channel for Nitinol medical devices, particularly in fields such as cardiology, orthopedics, and urology. These clinics often focus on specific medical areas, allowing for specialized care and enhanced procedural efficiency. The increasing number of specialty clinics and their growing patient base are driving demand for advanced Nitinol devices tailored to their specific treatment needs. As patients increasingly seek targeted treatments from specialized providers, the reliance on Nitinol technology in these settings is likely to expand, contributing positively to market growth.

Online Stores :

The rise of digital healthcare has led to the growing prominence of online stores as a distribution channel for Nitinol medical devices. The convenience of purchasing medical devices online has made it easier for healthcare providers to access a broader range of products without the constraints of traditional procurement processes. Online platforms also provide detailed information and reviews about products, empowering purchasing decisions. As e-commerce continues to grow, the online distribution channel for Nitinol medical devices is expected to experience significant growth, driven by increasing consumer preferences for digital solutions.

Retail Pharmacies :

Retail pharmacies are increasingly becoming an essential distribution channel for Nitinol medical devices. These establishments cater to a broader range of patients, providing access to medical supplies and devices that can be utilized for home care or minor procedures. The convenience of purchasing essential devices from local pharmacies is driving demand, especially for outpatient treatments requiring Nitinol products. As pharmacies expand their product offerings and enhance their role in patient care, the distribution of Nitinol devices through retail channels is expected to grow, contributing to overall market expansion.

Direct Sales :

Direct sales remain a vital distribution channel for Nitinol medical devices, primarily through manufacturers selling directly to hospitals, clinics, and healthcare providers. This channel allows manufacturers to maintain closer relationships with their customers, ensuring better service and support. The trend towards personalized solutions and customer-focused services has prompted many manufacturers to enhance their direct sales strategies. As healthcare providers seek high-quality devices tailored to their specific needs, direct sales of Nitinol medical devices are anticipated to grow, reflecting the increasing focus on customer satisfaction within the market.

By Material Type

Nickel-Titanium :

Nickel-titanium, commonly known as Nitinol, is a widely utilized material in the production of various medical devices due to its unique properties, such as shape memory effect and superelasticity. This material allows for devices to return to their original shape after deformation, providing significant advantages in minimally invasive applications. The biocompatibility of nickel-titanium further enhances its appeal in the medical field, making it suitable for implantable devices that require long-term stability within the human body. As demand for advanced medical solutions continues to rise, the utilization of nickel-titanium in manufacturing will likely expand, supporting market growth.

Nickel-Titanium-Zirconium :

Nickel-titanium-zirconium alloys are gaining attention in the Nitinol medical devices market due to their enhanced mechanical properties and corrosion resistance compared to traditional Nitinol. The addition of zirconium improves the strength and fatigue resistance of the material, making it particularly suitable for applications requiring greater durability and longevity. As manufacturers seek to develop devices that can withstand prolonged exposure to bodily fluids and stress, the use of nickel-titanium-zirconium in medical applications is expected to grow, driven by the demand for higher performance and reliability in Nitinol devices.

Nickel-Titanium-Hafnium :

Nickel-titanium-hafnium alloys represent a cutting-edge advancement in the Nitinol medical devices market, offering improved thermal stability and enhanced shape memory properties. The incorporation of hafnium into the alloy can lead to better performance in extreme conditions, making it suitable for specialized applications such as endovascular interventions. The unique characteristics of nickel-titanium-hafnium alloys can help reduce the failure rate of devices and improve patient outcomes. As the medical field continues to evolve, the demand for advanced materials like nickel-titanium-hafnium is expected to increase, supporting the growth of this segment.

Nickel-Titanium-Copper :

Nickel-titanium-copper alloys are another innovative material gaining traction in the Nitinol medical devices market. This material combines the desirable properties of nickel-titanium with the unique characteristics of copper, leading to enhanced shape memory behavior and superelasticity. The flexibility and adaptability of nickel-titanium-copper alloys make them suitable for a wide range of applications, particularly in areas such as interventional cardiology and vascular surgery. The increasing demand for devices that can effectively respond to physiological changes underscores the growth potential of this material type within the Nitinol device market.

By Region

The North American region currently dominates the Nitinol medical devices market, accounting for over 40% of the global market share. This dominance is attributed to the presence of advanced healthcare infrastructure, significant investments in medical research, and a high prevalence of chronic diseases necessitating surgical interventions. The United States, in particular, stands out as a key contributor to market growth, primarily driven by the adoption of minimally invasive procedures and the increasing prevalence of cardiovascular and orthopedic conditions. Furthermore, the North American market is projected to grow at a CAGR of 10.5% during the forecast period, fueled by ongoing innovations in Nitinol technology and robust regulatory support for new product approvals.

In Europe, the Nitinol medical devices market is also witnessing strong growth, with a considerable share attributed to the increasing adoption of advanced medical technologies in countries such as Germany, France, and the United Kingdom. The European market is characterized by a growing aging population, leading to higher incidences of chronic diseases and an increased need for innovative medical solutions. The introduction of new medical devices and the expansion of existing product lines are further bolstering market growth in this region. The European market is expected to grow at a CAGR of 9.7%, reflecting the ongoing demand for high-quality Nitinol devices across various medical applications.

Opportunities

The Nitinol medical devices market presents numerous opportunities for growth driven by the ongoing advancements in technology and materials science. One of the most promising opportunities lies in the development of next-generation Nitinol devices that incorporate smart technologies, such as sensors and data analytics capabilities. These advancements could enhance the functionality of medical devices, enabling real-time monitoring and improved patient outcomes. Additionally, as healthcare providers increasingly adopt digital solutions, integrating Nitinol devices with telehealth applications presents a unique opportunity to enhance patient management and streamline care delivery. Furthermore, emerging markets in Asia and Latin America represent significant growth avenues, as rising healthcare expenditures and improving infrastructure pave the way for increased adoption of advanced medical technologies.

Another opportunity fueling growth in the Nitinol medical devices market is the rising focus on personalized medicine. As healthcare becomes more patient-centric, the demand for customized medical solutions tailored to individual patient needs is increasing. This trend is particularly relevant in the context of Nitinol devices, which can be engineered and manufactured to fit specific anatomical requirements. By collaborating with healthcare providers and investing in research and development, manufacturers can capitalize on this shift towards personalized medical solutions, positioning themselves favorably within the competitive landscape. Additionally, partnerships and collaborations among companies and research institutions can foster innovation and accelerate the development of new Nitinol technologies, further driving market growth.

Threats

While the Nitinol medical devices market is poised for significant growth, it faces several threats that could impact its trajectory. One of the primary threats is the increasing scrutiny and regulatory hurdles associated with medical device approvals. As regulatory bodies impose stricter guidelines, manufacturers may face challenges in bringing new Nitinol devices to market efficiently. The lengthy approval processes can hinder innovation and delay access to advanced medical solutions, ultimately affecting the market's growth potential. Additionally, the competitive landscape is becoming increasingly saturated, with numerous players vying for market share. This competition may lead to price wars and reduced profit margins, particularly for smaller manufacturers that may lack the resources to compete effectively.

Furthermore, fluctuations in raw material prices, particularly nickel and titanium, could pose a risk to manufacturers in the Nitinol medical devices market. Variability in these prices can impact production costs, leading to challenges in maintaining competitive pricing. Additionally, the potential for supply chain disruptions caused by geopolitical tensions or natural disasters may further exacerbate these challenges. Manufacturers must navigate these threats effectively to ensure sustainable growth in the Nitinol medical devices market, focusing on strategies that enhance resilience and adaptability.

Competitor Outlook

• Bard Medical
• Medtronic
• Boston Scientific
• Cook Medical
• Abbott Laboratories
• Johnson & Johnson
• Terumo Corporation
• St. Jude Medical
• Merit Medical Systems
• Conmed Corporation
• Biotronik
• Smith & Nephew
• Stryker Corporation
• Teleflex Incorporated
• Imricor Medical Systems

The competitive landscape of the Nitinol medical devices market is characterized by a diverse array of key players focused on innovation and product development. Major companies are investing heavily in research and development to create advanced Nitinol devices that cater to the evolving needs of healthcare providers and patients. Collaborations and partnerships among companies, along with strategic mergers and acquisitions, are common strategies employed to enhance market presence and expand product portfolios. As a result, the competitive rivalry within this market is expected to intensify, prompting companies to continuously innovate and improve their offerings to maintain a competitive edge.

Among the key players, Medtronic stands out as a leader in the Nitinol medical devices market, known for its extensive range of cardiovascular devices and commitment to research and development. The company has established a strong reputation in the market through its continuous innovation and high-quality product offerings. Additionally, Boston Scientific is another prominent competitor, focusing on creating cutting-edge Nitinol stents and guidewires designed to enhance procedural efficiency and improve patient outcomes. The company’s emphasis on technological advancements and collaborations reinforces its position in the market.

Furthermore, Cook Medical is recognized for its contributions to the Nitinol medical devices market, particularly in the development of innovative retrieval devices and filters. The company’s dedication to addressing healthcare challenges through advanced technology has positioned it as a key player in this sector. Similarly, Abbott Laboratories has made significant strides in the market, leveraging its expertise in medical technology and patient care to develop Nitinol devices that meet the growing demands of clinicians. The competitive dynamics within the Nitinol medical devices market will continue to evolve as companies strive to differentiate themselves and capitalize on emerging opportunities.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Biotronik
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Bard Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smith & Nephew
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 St. Jude Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Boston Scientific
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Johnson & Johnson
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Conmed Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Terumo Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Abbott Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Stryker Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Merit Medical Systems
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Teleflex Incorporated
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Imricor Medical Systems
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nitinol Medical Devices Market, By Application
    • 6.1.1 Endovascular
    • 6.1.2 Orthopedic
    • 6.1.3 Dental
    • 6.1.4 Neurology
    • 6.1.5 Urology
  • 6.2 Nitinol Medical Devices Market, By Product Type
    • 6.2.1 Stents
    • 6.2.2 Guidewires
    • 6.2.3 Filters
    • 6.2.4 Catheters
    • 6.2.5 Retrieval Devices
  • 6.3 Nitinol Medical Devices Market, By Material Type
    • 6.3.1 Nickel-Titanium
    • 6.3.2 Nickel-Titanium-Zirconium
    • 6.3.3 Nickel-Titanium-Hafnium
    • 6.3.4 Nickel-Titanium-Copper
  • 6.4 Nitinol Medical Devices Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Online Stores
    • 6.4.4 Retail Pharmacies
    • 6.4.5 Direct Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Nitinol Medical Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nitinol Medical Devices market is categorized based on

By Product Type

• Stents
• Guidewires
• Filters
• Catheters
• Retrieval Devices

By Application

• Endovascular
• Orthopedic
• Dental
• Neurology
• Urology

By Distribution Channel

• Hospitals
• Specialty Clinics
• Online Stores
• Retail Pharmacies
• Direct Sales

By Material Type

• Nickel-Titanium
• Nickel-Titanium-Zirconium
• Nickel-Titanium-Hafnium
• Nickel-Titanium-Copper

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Bard Medical
• Medtronic
• Boston Scientific
• Cook Medical
• Abbott Laboratories
• Johnson & Johnson
• Terumo Corporation
• St. Jude Medical
• Merit Medical Systems
• Conmed Corporation
• Biotronik
• Smith & Nephew
• Stryker Corporation
• Teleflex Incorporated
• Imricor Medical Systems